Clinical Trial Update: TDT 067 Open Label Multi-Dose Onychomycosis Study [Phase 2]

View source ↗

Summary

Phase 2 open-label multi-dose study of TDT 067 for onychomycosis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Onychomycosis

Drugs mentioned

• TDT 067

Snippet

Sponsor: Celtic Pharma Development Services | Conditions: Onychomycosis | Phase 2 | Status: COMPLETED